共 50 条
- [41] CLINICAL OUTCOMES OF THE USE OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM (CCH) FOR PEYRONIE'S DISEASE (PD) JOURNAL OF UROLOGY, 2017, 197 (04): : E756 - E757
- [42] COMPARISON OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM TO SURGERY FOR THE MANAGEMENT OF PEYRONIE'S DISEASE: A RANDOMIZED TRIAL JOURNAL OF UROLOGY, 2022, 207 (05): : E409 - E409
- [43] Surgical Correction of Persistent Peyronie's Disease Following Collagenase Clostridium Histolyticum Treatment JOURNAL OF SEXUAL MEDICINE, 2015, 12 (01): : 259 - 264
- [44] Collagenase Clostridium histolyticum for the Treatment of Peyronie's Disease: The Development of This Novel Pharmacologic Approach JOURNAL OF SEXUAL MEDICINE, 2015, 12 (06): : 1481 - 1489
- [46] Collagenase Clostridium Histolyticum for the Treatment of Peyronie’s Disease: A ‘Real World’ Clinical Perspective Drugs, 2016, 76 : 1523 - 1528
- [47] The Impact of Clostridium Histolyticum Collagenase on the Prevalence and Management of Peyronie's Disease in the United States WORLD JOURNAL OF MENS HEALTH, 2019, 37 (02): : 234 - 239
- [49] IMPACT OF NUMBER OF CYCLES OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM ON OUTCOMES IN PATIENTS WITH PEYRONIE'S DISEASE JOURNAL OF UROLOGY, 2016, 195 (04): : E1061 - E1061